Topical Panretin data

Final analysis of a Phase I/II trial showed reduction or elimination of KS lesions treated with Panretin, according to

Read the full 191 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE